Li Dean Y 4

What Happened
Li Dean Y, Executive Vice President & President of Merck Research Laboratories (MRL), sold 10,235 Merck shares in an open-market sale on February 10, 2026. The reported weighted-average price was $117.52 per share (range shown below), generating roughly $1,202,844 in proceeds. This was a sale (liquidity event), which is typically routine and does not by itself indicate a change in company outlook.

Key Details

• Transaction date: 2026-02-10 — open market sale (transaction code S).
• Shares sold: 10,235 at a weighted-average price of $117.52; total proceeds ≈ $1,202,844.
• Price range disclosed: $117.5200 to $117.5550; the filing notes the price is a weighted average and the filer can provide per-price details on request.
• Shares owned after transaction: Not reported in this Form 4.
• Filing timeliness: Reported with a period of report matching the transaction date (no late filing indicated in this record).

Context
Sales by executives are often for personal liquidity or routine reasons; purchases generally carry more informational weight for investors. The filing includes a footnote clarifying the sale was executed in multiple trades at slightly different prices (hence the weighted average).